Literature DB >> 1592477

Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.

T Imai1, Y Hirata, T Emori, M Yanagisawa, T Masaki, F Marumo.   

Abstract

To elucidate the cellular mechanism of endothelin-1 biosynthesis induced by angiotensin and vasopressin, we first cloned and sequenced full-length bovine preproendothelin-1 complementary DNA (cDNA) from a cultured bovine carotid artery endothelial cell cDNA library. The predicted bovine preproendothelin-1 consists of 202 amino acid residues and has a high percentage of homology to human, porcine, and rat preproendothelin-1 (70%, 81%, and 77%, respectively). Big endothelin-1, an intermediate form, consists of 39 residues differing only at position Val28 from porcine (Ile28) and His27 from rat (Arg27). The predicted 21-residue mature endothelin-1 is identical to human, porcine, rat, canine, and mouse endothelin-1. Northern blot analysis with the cloned cDNA as a probe demonstrated that a single 2.3-kb preproendothelin-1 messenger RNA (mRNA) is expressed not only in endothelial cells, but also in various bovine tissues, including lung, brain, heart, intestine, kidney, ovary, and urinary bladder. Angiotensin II and arginine vasopressin immediately and dose-dependently induced expression of preproendothelin-1 mRNA, whose effects were abolished by specific receptor antagonists. These findings suggest that stimulation of endothelin-1 secretion from endothelial cells by both agonists may be principally due to induction of preproendothelin-1 mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592477     DOI: 10.1161/01.hyp.19.6.753

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

1.  Angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Lidiana D Almeida-Paula; Joseph W Harding; D Neil Granger
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

Review 2.  Endothelial dysfunction in obstructive sleep apnea.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2007-06-15       Impact factor: 4.062

Review 3.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 4.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  Inhibition of ENaC by endothelin-1.

Authors:  Andrey Sorokin; Alexander Staruschenko
Journal:  Vitam Horm       Date:  2015-03-06       Impact factor: 3.421

6.  Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure.

Authors:  Ulla C Kopp; Michael Z Cicha; Susan Y Jones
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

Review 7.  The role of endothelin receptor antagonists in the treatment of chronic heart failure.

Authors:  W Kiowski; G Sütsch
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

8.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

Authors:  H Ito; Y Hirata; S Adachi; M Tanaka; M Tsujino; A Koike; A Nogami; F Murumo; M Hiroe
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

9.  Effects of clofibrate on salt loading-induced hypertension in rats.

Authors:  Antonio Cruz; Isabel Rodríguez-Gómez; Rocío Pérez-Abud; Miguel Ángel Vargas; Rosemary Wangensteen; Andrés Quesada; Antonio Osuna; Juan Manuel Moreno
Journal:  J Biomed Biotechnol       Date:  2010-10-14

10.  Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells.

Authors:  N Farhat; C C Matouk; A M Mamarbachi; P A Marsden; B G Allen; E Thorin
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.